Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation

被引：28
|
作者：
Van Bömmel, F [1 ]
Schernick, A [1 ]
Hopf, U [1 ]
Berg, T [1 ]
机构：
[1] Humboldt Univ, Charite, Med Klin Scherpunkt Hepatol & Gastroenterol, Berlin, Germany
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 02期
关键词：
D O I：
10.1053/gast.2003.1240586b
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：586 / 587
页数：2
相关论文
共 50 条
  • [21] Reactivation of lamivudine-resistant occult hepatitis B in an HIV-infected patient undergoing cytotoxic chemotherapy
    Schnepf, Nathalie
    Sellier, Pierre
    Bendenoun, Marc
    Zini, Jean-Marc
    Sanson-le pors, Marie-Jose
    Mazeron, Marie-Christine
    JOURNAL OF CLINICAL VIROLOGY, 2007, 39 (01) : 48 - 50
  • [22] Clinical Results of Tenofovir Disoproxil Fumarate in a Hemodialysis Patient with Chronic Hepatitis B
    Aomura, Daiki
    Tachibana, Naoki
    Komatsu, Michiharu
    Kobayashi, Masakazu
    CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2020, 10 (03): : 130 - 138
  • [23] Association of Lamivudine-Resistant Mutational Patterns With the Antiviral Effect of Adefovir in Patients With Chronic Hepatitis B
    Cha, Choong Keun
    Kwon, Hyeok Choon
    Cheong, Jae Youn
    Cho, Sung Won
    Hong, Sun Pyo
    Kim, Soo-Ok
    Yoo, Wang Don
    JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (03) : 417 - 424
  • [24] Physician testing for HIV in patients treated with tenofovir disoproxil fumarate and lamivudine monotherapy for hepatitis B virus
    Lau, Jillian S. Y.
    Ratnam, Dilip
    Woolley, Ian
    SEXUAL HEALTH, 2018, 15 (01) : 89 - 90
  • [25] Tenofovir disoproxil fumarate for patients with chronic hepatitis B who have previously failed lamivudine and adefovir
    Patterson, S. J.
    George, J.
    Strasser, S. I.
    Lee, A. U.
    Sievert, W.
    Nicoll, A. J.
    Desmonad, P. V.
    Roberts, S. K.
    Locarnini, S.
    Bowden, S.
    Angus, P. W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A302 - A302
  • [26] Tenofovir disoproxil fumarate-induced severe liver injury in a patient with chronic hepatitis B virus infection
    Kang, Min Kyu
    Park, Jung Gil
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (06) : 628 - 630
  • [27] Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patient with chronic hepatitis B
    Nam, Heechul
    Han, Ji Won
    Lee, Soon Kyu
    Yang, Hyun
    Lee, Hae Lim
    Sung, Pil Soo
    Song, Myeong Jun
    Kwon, Jung Hyun
    Jang, Jeong Won
    Chang, U-Im
    Kim, Chang Wook
    Nam, Soon Woo
    Bae, Si Hyun
    Choi, Jong Young
    Yoon, Seung Kew
    Yang, Jin Mo
    Kim, Hee Yeon
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (08) : 1673 - 1683
  • [28] Lamivudine/tenofovir withdrawalFatal hepatitis B reactivation in an elderly patient: case report
    Reactions Weekly, 2014, 1489 (1) : 21 - 21
  • [29] Long-term effect of tenofovir in the treatment of lamivudine-resistant hepatitis B virus infections in comparison to adefovir
    van Bömmel, F
    Mauss, S
    Zollner, B
    Schürmann, D
    Bergk, A
    Feucht, HH
    Wiedenmann, B
    Berg, T
    HEPATOLOGY, 2005, 42 (04) : 269A - 269A
  • [30] Tenofovir Alafenamide for Drug-Resistant Hepatitis B: A Randomized Trial for Switching From Tenofovir Disoproxil Fumarate
    Byun, Kwan Soo
    Choi, Jonggi
    Kim, Ji-Hoon
    Lee, Yung Sang
    Lee, Han Chu
    Kim, Yoon Jun
    Yoo, Byung Chul
    Kwon, So Young
    Gwak, Geum-Youn
    Lim, Young-Suk
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (02) : 427 - 437
12345